Doppler Optical Frequency Domain Imaging Instrument
多普勒光频域成像仪
基本信息
- 批准号:7793981
- 负责人:
- 金额:$ 25.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-01 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnesthesia proceduresAnimal ModelAnimalsArtsBiomedical EngineeringBloodBlood VesselsCell SurvivalContrast MediaDermatologyDisseminated Malignant NeoplasmEvaluationExperimental NeoplasmsFrequenciesFunctional disorderFundingGeneral HospitalsGrantGrowthHousingImageImaging TechniquesImaging technologyInterventionInvestigational TherapiesLaboratoriesLeadLymphatic vesselMalignant NeoplasmsMassachusettsMeasurementMicroscopyMissionMolecularMonitorMorphologyOpticsPathologic ProcessesPathway interactionsPhysiologicalProgram Research Project GrantsProtocols documentationRadiation OncologyResearchResearch PersonnelResearch Project GrantsResolutionScientistSolidSolid NeoplasmSpeedTechnologyTissue ViabilityTracerTumor BiologyTumor TissueTumor VolumeTumor-Associated VasculatureUnited States National Institutes of Healthanti-cancer therapeuticcancer therapycombatcostfightingin vivoinstrumentmeetingsneoplastic cellnovelnovel therapeutic interventionnovel therapeuticspublic health relevanceresponsetreatment strategytumortumor progression
项目摘要
DESCRIPTION (provided by applicant): The application of multiphoton microscopy (MPM) to the study of solid tumor biology in vivo has elucidated pathways and mechanisms of cancer progression and has motivated new therapeutic strategies and approaches. Current high-resolution intravital imaging techniques, however, can only be used to visualize tumor microstructure and vascular morphology superficially (300-400 5m depth) and only over volumetric regions that are a fraction of the total tumor volume. Additionally, longitudinal imaging is often limited in frequency due to the accumulation of exogenous contrast agents. Here we propose to purchase a state-of-the- art Doppler Optical Frequency Domain Imaging (OFDI) instrument, which overcomes these limitations of MPM and is a complementary technology. Using Doppler OFDI, we will be able to image a field up to 5.8 mm by 7.8 mm and more than 2 mm deep in 15 minutes, a significant increase both image volume and imaging speed compared to MPM. The imaging technique does not require the use of tracers, allowing for frequent, repeated timepoint measurements. This will accelerate research on our currently funded NIH grants and reduce the cost of our research over the long term. The Doppler OFDI instrument would be dedicated to small animal imaging and housed in the Steele Laboratories at Massachusetts General Hospital, whose mission is to understand the pathophysiology of solid tumors and develop novel, curative therapies for primary and metastatic cancers. The Doppler OFDI instrument will accelerate research on more than ten NIH research grants, including one Program Project Grant, two Bioengineering Research Partnership Grants and 3 R01 grants. Each grant relies upon intravital imaging to probe the growth, invasion and response of tumors to different experimental therapies in animal models. As an example, the Program Project Grant (P01-CA080124) relies upon MPM to monitor vascular normalization in response to different molecular interventions and treatment approaches. Using Doppler OFDI, we will evaluate vascular changes throughout the entire experimental tumor, which would normally require prolonged anesthesia and cumbersome imaging protocols using MPM and would only achieve about 20% of the image depth at best. Furthermore, with Doppler OFDI we will be able to monitor changes in tumor associated lymphatic vessels and changes in tumor tissue viability. Thus Doppler OFDI will facilitate the exploration of physiological and pathological processes and the evaluation of treatment strategies in order to fight the growth and spread of cancer. The facility will be shared by multiple investigators, including scientists from the Departments of Radiation Oncology and Dermatology at MGH, and will be critical for meeting the aims of ongoing NIH-funded projects of these investigators as well as many planned projects. Doppler OFDI will allow critical questions to be addressed that have not been answered due to the lack of this enabling technology and will open new avenues of research that will lead us closer to new therapies for cancer.
Public Health Relevance: The ability to monitor and interrogate changes in tumor cell viability, tumor blood vasculature and tumor associated lymphatic vessels is critical to identify successful novel therapeutic approaches to combat the growth and spread of solid cancers. To date, the ability to monitor these parameters with the necessary spatial and temporal resolution has been limited by the current state of the imaging technology. In this application, we propose to purchase a novel state-of-the-art Doppler optical frequency domain imaging instrument, which overcomes many of the limitations of current imaging technologies, for dedicated use in the evaluation of novel anti-cancer therapeutics in small animals.
描述(由申请人提供):多光子显微镜(MPM)在体内研究实体瘤生物学研究中的应用已阐明了癌症进展的途径和机制,并激发了新的治疗策略和方法。但是,当前的高分辨率浸润成像技术只能用于表面上可视化肿瘤微观结构和血管形态(300-400 5M深度),而仅超过体积区域,这是总肿瘤总量的一部分。另外,由于外源对比剂的积累,纵向成像通常受到频率的限制。在这里,我们建议购买最先进的多普勒光学频域成像(OFDI)仪器,该仪器克服了MPM的这些局限性,并且是一种补充技术。使用多普勒OFDI,我们将能够在15分钟内成像高达5.8毫米x 7.8 mm和2 mm的场,与MPM相比,图像体积和成像速度显着提高。成像技术不需要使用示踪剂,从而允许频繁,重复的时间点测量。这将加速对我们目前资助的NIH赠款的研究,并降低长期研究的成本。 Doppler Ofdi仪器将专用于小动物成像,并安置在马萨诸塞州综合医院的Steele实验室中,其任务是了解实体瘤的病理生理学,并开发用于原发性和转移性癌症的新型治疗疗法。 Doppler Ofdi仪器将加速对十多种NIH研究补助金的研究,其中包括一项计划项目赠款,两个生物工程研究合作伙伴赠款和3份R01赠款。每个赠款都依靠浸润成像来探测肿瘤对动物模型中不同实验疗法的生长,侵袭和反应。例如,计划项目赠款(P01-CA080124)依靠MPM来监测对不同分子干预和治疗方法的响应。使用多普勒OFDI,我们将评估整个实验性肿瘤的血管变化,通常需要使用MPM延长麻醉和繁琐的成像方案,并且最多只能达到图像深度的20%。此外,使用多普勒OFDI,我们将能够监测肿瘤相关淋巴管的变化以及肿瘤组织生存能力的变化。因此,多普勒的多普勒将促进生理和病理过程的探索以及治疗策略的评估,以抗击癌症的生长和传播。该设施将由多个研究人员共享,包括MGH辐射肿瘤学和皮肤病学部门的科学家,对于实现这些研究人员以及许多计划项目的NIH资助项目的目标至关重要。 Doppler Ofdi将允许解决由于缺乏这种有能力的技术而未得到回答的关键问题,并将开放新的研究途径,这将使我们更接近新的癌症疗法。
公共卫生相关性:监测和询问肿瘤细胞生存力,肿瘤血管和相关淋巴管的变化的能力对于确定成功的新型治疗方法以应对固体癌症的生长和扩散至关重要。迄今为止,通过成像技术的当前状态限制了用必要的空间和时间分辨率监视这些参数的能力。在此应用中,我们建议购买一种新型的最先进的多普勒光学频域成像仪器,该仪器克服了当前成像技术的许多局限性,用于评估小动物的新型抗癌治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dai Fukumura其他文献
Dai Fukumura的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dai Fukumura', 18)}}的其他基金
Reprogramming the Tumor Microenvironment to Improve Immunotherapy of Glioblastoma by Co-Targeting VEGF and Ang2
通过共同靶向 VEGF 和 Ang2 重新编程肿瘤微环境以改善胶质母细胞瘤的免疫治疗
- 批准号:
10582613 - 财政年份:2021
- 资助金额:
$ 25.96万 - 项目类别:
Reprogramming the tumor microenvironment to improve immunotherapy of glioblastoma by co-targeting VEGF and Ang2
通过共同靶向 VEGF 和 Ang2 重新编程肿瘤微环境以改善胶质母细胞瘤的免疫治疗
- 批准号:
10394968 - 财政年份:2021
- 资助金额:
$ 25.96万 - 项目类别:
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
重新设计肥胖引起的异常微环境以改善 PDAC 治疗
- 批准号:
9403496 - 财政年份:2017
- 资助金额:
$ 25.96万 - 项目类别:
Overcoming Resistance to Anti-VEGF Treatment of Colorectal Cancers
克服结直肠癌抗 VEGF 治疗的耐药性
- 批准号:
8463132 - 财政年份:2013
- 资助金额:
$ 25.96万 - 项目类别:
Vascular Normalization: Rolse of Perivascular Cells
血管正常化:血管周围细胞的旋转
- 批准号:
7118413 - 财政年份:2006
- 资助金额:
$ 25.96万 - 项目类别:
NO in Tumor Angiogenesis,Microcirculation & Rad.Therapy
NO在肿瘤血管生成、微循环中的作用
- 批准号:
7071781 - 财政年份:2002
- 资助金额:
$ 25.96万 - 项目类别:
Nitric Oxide in Tumor Angiogenesis, Microcirculation and Radiation Therapy
一氧化氮在肿瘤血管生成、微循环和放射治疗中的作用
- 批准号:
7618192 - 财政年份:2002
- 资助金额:
$ 25.96万 - 项目类别:
NO in Tumor Angiogenesis,Microcirculation & Rad.Therapy
NO在肿瘤血管生成、微循环中的作用
- 批准号:
6522149 - 财政年份:2002
- 资助金额:
$ 25.96万 - 项目类别:
Nitric Oxide in Tumor Angiogenesis, Microcirculation and Radiation Therapy
一氧化氮在肿瘤血管生成、微循环和放射治疗中的作用
- 批准号:
7812092 - 财政年份:2002
- 资助金额:
$ 25.96万 - 项目类别:
相似海外基金
Soft wireless multimodal cardiac implantable devices for long-term investigating heart failure pathogenesis
用于长期研究心力衰竭发病机制的软无线多模式心脏植入装置
- 批准号:
10735395 - 财政年份:2023
- 资助金额:
$ 25.96万 - 项目类别:
Development of an endometrial ablation drug-device combination to treat heavy menstrual bleeding
开发子宫内膜消融药物装置组合来治疗月经出血
- 批准号:
10759501 - 财政年份:2023
- 资助金额:
$ 25.96万 - 项目类别:
Large-scale calcium and voltage imaging to illuminate neural mechanisms of visual experience
大规模钙和电压成像阐明视觉体验的神经机制
- 批准号:
10753172 - 财政年份:2023
- 资助金额:
$ 25.96万 - 项目类别:
A Nonhuman Primate Model for Postoperative Delirium and Working Memory Impairment
术后谵妄和工作记忆损伤的非人类灵长类动物模型
- 批准号:
10592515 - 财政年份:2023
- 资助金额:
$ 25.96万 - 项目类别:
Testing Cerebroprotective Interventions with Rodent Ischemic Stroke Models
用啮齿动物缺血性中风模型测试脑保护干预措施
- 批准号:
10588601 - 财政年份:2023
- 资助金额:
$ 25.96万 - 项目类别: